Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide in transfusion-dependent MDS with del(5q)
NCT00874978Phase 2Completed
- Sponsor
- King's College Hospital
- Start
- Jan 2005
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in myelodysplastic syndrome (MDS), sponsored by King's College Hospital. Started Jan 2005; status: completed.
02
Drugs
lenalidomide
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT00874978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00874978.